DUBLIN–(BUSINESS WIRE)–The “Western Blotting Market by Product, (Consumables (Antibody), Instrument (Electrophoresis, Blotting System, Imager (Fluorescent))), Application (Biomedical, Clinical Diagnostics), End User (Research Institute, Hospital, Biopharma) – Global Forecast to 2026” report has been added to ResearchAndMarkets.com’s offering.
The global western blotting market is projected to reach USD 1.4 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 6.7% during the forecast period.
Technological advancements, increasing government funding in the field of biomedical research, growing demand for personalized medicine, and the rising prevalence of HIV are the key factors driving the market growth.
By instruments segment, the imagers sub segment accounted for the fastest-growing segment of the western blotting market
Based on instruments, the western blotting market is segmented into gel electrophoresis instruments, blotting systems, and imagers. Growth in this product segment is primarily due to the automation of imagers, which simplifies the protein detection process.
By end user segment, the academic & research institutes segment accounted for the largest share of the western blotting market
Based on end users, the western blotting market is segmented into academic & research institutes, biopharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, and other end users. In 2020, academic & research institutes accounted for the largest share of the western blotting market. The large share of the academic & research institutes end-user segment can be attributed to growing government investments for research activities and increasing research in the area of proteomics.
Asia Pacific: The fastest-growing region in the western blotting market.
The western blotting market in the Asia Pacific region is projected to register the highest growth during the forecast period. The major factors driving the growth of the Asia Pacific market include strong government support for the growth of the pharmaceutical and biotechnology industry, the presence of bioclusters in China and India, increasing funding for life science research, and growing initiatives related to target disease diagnosis.
North America: the largest share of the western blotting market
In 2020, North America accounted for the largest share of the western blotting market. The major factors driving the growth of this regional market include the presence of top manufacturers of western blotting products in this region, rise in research funding, increasing investments in proteomics research, and growing focus on personalized medicine.
Market Dynamics
Drivers
- Technological Advancements
- Increasing Government Funding in the Field of Biomedical Research
- Growing Demand for Personalized Medicine
- Rising Global Prevalence and Incidence of HIV/AIDS
Restraints
- Emergence of Alternative Technologies
Opportunities
- Emerging Economies
Challenges
- Requirement of High Procedural Efficiency for Accurate Results
Companies Mentioned
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Bio-Techne Corporation
- Merck KGaA
- Perkinelmer, Inc.
- Abcam plc
- Enzo Biochem, Inc.
- Li-Cor, Inc.
- Advansta Inc.
- Cell Signaling Technology, Inc.
- Azure Biosystems, Inc.
- Boster Biological Technology
- Geno Technology Inc.
- Stressmarq Biosciences Inc.
- F. Hoffmann-La Roche Ltd.
- Rockland Immunochemicals, Inc.
- Precision Biosystems
- Cleaver Scientific Ltd.
- Proteintech Group
- Abnova Corporation
- Sino Biological Inc.
- Abbexa Ltd.
- Covalab S.A.S.
- Biorbyt Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/fh6p1b
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900